Biology and significance of alpha‐fetoprotein in hepatocellular carcinomaPeter R. Galle, Andrew X. Zhu, Friedrich Foerster et al.|Liver International|2019Cited by 591
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Cathy Eng, Takayuki Yoshino et al.|The Lancet|2023Cited by 319